过去一年中添加的文章，按日期排序
[引用][C] A CASE SERIES OF BRONCHIOLITIS OBLITERANS AS A COMPLICATION OF CHRONIC GRAFT VS HOST DISEASE: REVIEW OF CLINICAL …
A PARSONS, M MERANDA, DJ FRANCO-PALACIOS - CHEST, 2024 - journal.chestnet.org
4 天前 - … access to pharmacologic and non-pharmacologic treatments as well as timely referral
for lung … All patients had moderate to severe obstruction (median FEV1 of 0.86 L; 28.5% of …
for lung … All patients had moderate to severe obstruction (median FEV1 of 0.86 L; 28.5% of …
Striving for Stability in Patients with COPD: A New Way Forward?
MLK Han, LEGW Vanfleteren, S Kolterer, R Stacey… - … in Therapy, 2024 - Springer
12 天前 - … During the session, the speakers (MeiLan Han, Lowie Vanfleteren and Dave Singh)
highlighted the specific challenges of chronic obstructive pulmonary disease (COPD), such …
highlighted the specific challenges of chronic obstructive pulmonary disease (COPD), such …
[PDF][PDF] A Rare Presentation of a Transverse Mesocolic Internal Hernia: A Case Report
DA Rowe, WB Bowers, HL Mateja, EF Rivera, LK Umbu… - Cureus, 2024 - cureus.com
16 天前 - … a sudden onset of severe, diffuse abdominal pain. Her medical history was significant
for systemic lupus erythematosus, pulmonary fibrosis, multiple pulmonary embolisms, and …
for systemic lupus erythematosus, pulmonary fibrosis, multiple pulmonary embolisms, and …
[PDF][PDF] Curcuma longa L: A Promising Drug against Respiratory Disorders
Z Shafique, T Afzaal, K Ahmed, K Hanif, A Tariq… - uniquescientificpublishers.com
20 天前 - … having a broad range of pharmacological characteristics. Many phytochemicals are
… pulmonary diseases like chronic obstructive pulmonary disorder (COPD), acute respiratory …
… pulmonary diseases like chronic obstructive pulmonary disorder (COPD), acute respiratory …
Progress in Utilizing Chitosan-Based Nanoparticles for Pulmonary Drug Administration
21 天前 - … diseases such as asthma, chronic obstructive pulmonary disease, pneumonia, cystic
fibrosis, and lung … ameliorate the treatment landscape of pulmonary diseases. Emphasis is …
fibrosis, and lung … ameliorate the treatment landscape of pulmonary diseases. Emphasis is …
Clinical characteristics and management strategies of chronic obstructive pulmonary disease in high-altitude areas
GUO Chenxia, Q Bianba, N Yanping… - … Management, 2024 - pesquisa.bvsalud.org
25 天前 - … obstructive pulmonary disease (COPD) in high-altitude areas.… severe with more
acute exacerbations in the past year, and most patients do not receive standardized medication. …
acute exacerbations in the past year, and most patients do not receive standardized medication. …
[HTML][HTML] … with the ratio between the main pulmonary artery and ascending aorta diameter in patients with acute exacerbation of chronic obstructive pulmonary disease
JK Lee, BG Kho, JY Yoon, CS Yoon… - … of Thoracic Disease, 2024 - jtd.amegroups.org
25 天前 - … chronic obstructive pulmonary disease (COPD) and long-term mortality in patients
with stable … Methods: We retrospectively reviewed the medical charts of patients admitted to a …
with stable … Methods: We retrospectively reviewed the medical charts of patients admitted to a …
Ipratropium-induced bronchospasm in a Chronic Obstructive Pulmonary Disease patient-arare and serious clinical vignette of altered drug response: a case report
S Arun, A Anil, H Iyer, J Charan, SB Varthya… - 2024 - researchsquare.com
27 天前 - … management of various respiratory disorders. Primarily utilized in the pharmacotherapy
of chronic obstructive lung disease … of Chronic Obstructive Pulmonary Disease (COPD). …
of chronic obstructive lung disease … of Chronic Obstructive Pulmonary Disease (COPD). …
L-ascorbate Alleviates Chronic Obstructive Pulmonary Disease through the EGF/PI3K/AKT Signaling Axis
J Yao, L Zhang, Z Zhou, J Liu, J Cheng… - Current medicinal … - pubmed.ncbi.nlm.nih.gov
27 天前 - … In summary, based on network pharmacology and molecular docking analyses,
this study revealed that L-ascorbate affects COPD development by regulating the PI3K/AKT …
this study revealed that L-ascorbate affects COPD development by regulating the PI3K/AKT …
[HTML][HTML] Recent Advances in Lipid Nano-Carrier Systems for the Management of Inflammatory Diseases: A Comprehensive Review
K Anand, S Khawas, A Singh, R Kumari, N Sharma - jptrm.chitkara.edu.in
30 天前 - … for targeted drug delivery to treat various diseases. … Treatment of COPD: An
Overview of Systematic Reviews. International journal of chronic obstructive pulmonary disease…
Overview of Systematic Reviews. International journal of chronic obstructive pulmonary disease…